Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Receives CE Mark for Cystic Fibrosis Test

NEW YORK, Jan. 12 (GenomeWeb News) - The European Union approved Tm Bioscience to market its Tag-It Cystic Fibrosis Kit for diagnostic purposes, the company said yesterday.

 

Under the CE Mark, the company can market the genetic test to EU countries and other countries that recognize the designation.

 

The US Food and Drug Administration approved the kit as an in vitro device for diagnostic use.

 

The test detects and identifies mutations and variants in the cystic fibrosis transmembrane conductance regulator gene in human blood or blood spot specimens.

The Scan

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.